EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neisseria meningitidis serogroup B causing invasive disease, Italy, 2010–2021

Paola Vacca iD, Fenicia Vescio, Fortunato D'Ancona, Cecilia Fazio, Arianna Neri, Anna Carannante, Luigina Ambrosio, Florigio Romano Lista, Silvia Fillo iD, Andrea Ciammaruconi, Antonella Fortunato, Paola Stefanelli

PLOS One · 2025

DOI: 10.1371/journal.pone.0337446 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Paola Vacca und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy. Hauptthemen laut MEDLINE: Neisseria meningitidis, Serogroup B, Meningococcal Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In Italy, Invasive Meningococcal Disease (IMD) due to Neisseria meningitidis serogroup B (MenB) showed the highest incidence rates in infants under one year of age. This study describes the main characteristics of MenB responsible for invasive diseases circulating in Italy from 2010 to 2021. Data collected within the framework of National Surveillance System (NSS) for IMD were analysed. Serogroup confirmed IMD cases were included in the study. For unspecified meningococcal serogroup, a multinomial model was used to impute the serogroup. Antimicrobial susceptibility and genotyping by Sanger or whole genome sequencing were performed on viable meningococci. Core genome MLST (cgMLST) was evaluated using a gene-by-gene approach, and MenDeVAR analyses were used to assess potential coverage by MenB vaccines. A total of 1845 IMD cases were reported to the NSS, of which 704 were laboratory confirmed as MenB and another 232 were statistically attributed to this serogroup. The highest incidence rate for IMD due to MenB was observed in infants

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neisseria meningitidis, Serogroup BMeningococcal InfectionsHumansItalyInfantChild, PreschoolMaleChildFemaleAdolescentAdultMiddle AgedInfant, NewbornYoung AdultMultilocus Sequence TypingIncidenceSerogroupAnti-Bacterial AgentsAgedMicrobial Sensitivity Tests

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
  • Environmental and Social Epidemiology Unit, Istituto Superiore di Sanità, Rome, Italy.
  • Scientific Department, Army Medical Centre, Rome, Italy.

ORCID-Profile: Paola Vacca, Silvia Fillo

Zitieren

APA

Vacca, P., Vescio, F., D'Ancona, F., Fazio, C., Neri, A., Carannante, A., Ambrosio, L., Lista, F. R., Fillo, S., Ciammaruconi, A., Fortunato, A., & Stefanelli, P. (2025). Neisseria meningitidis serogroup B causing invasive disease, Italy, 2010–2021. PLOS One. https://doi.org/10.1371/journal.pone.0337446

Vancouver

Vacca P, Vescio F, D'Ancona F, Fazio C, Neri A, Carannante A, et al. Neisseria meningitidis serogroup B causing invasive disease, Italy, 2010–2021. PLOS One. 2025. doi:10.1371/journal.pone.0337446

BibTeX
@article{Vacca2025,
  author = {Vacca, Paola and Vescio, Fenicia and D'Ancona, Fortunato and Fazio, Cecilia and Neri, Arianna and Carannante, Anna and Ambrosio, Luigina and Lista, Florigio Romano and Fillo, Silvia and Ciammaruconi, Andrea and Fortunato, Antonella and Stefanelli, Paola},
  title = {Neisseria meningitidis serogroup B causing invasive disease, Italy, 2010–2021},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0337446}
}
Kostenlos starten →